BlackRock Fund Advisors’s CorMedix CRMD Stock Holding History

BlackRock Fund Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$163K	Buy	21,347 +627	+3%	+$6.34K	﹤0.01%	3474
2016 Q3	$261K	Buy	20,720 +3,107	+18%	+$29K	﹤0.01%	3366
2016 Q2	$175K	Sell	17,613 -166,528	-90%	-$2.54M	﹤0.01%	3504
2016 Q1	$2.44M	Sell	184,141 -638	-0.3%	-$6.19K	﹤0.01%	3027
2015 Q4	$1.88M	Buy	184,779 +4,930	+3%	+$56.8K	﹤0.01%	3163
2015 Q3	$1.79M	Buy	179,849 +16,165	+10%	+$249K	﹤0.01%	3140
2015 Q2	$3.17M	Buy	163,684 +152,750	+1,397%	+$5.24M	﹤0.01%	3090
2015 Q1	$538K	Buy	+10,934	New	+$259K	﹤0.01%	3255

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Spot Trading Chicago, Illinois $5.81B AUM 22.41% 1-Year Est. Return

BlackRock Fund Advisors's CRMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its CorMedix (CRMD) stake by 3% in Q4 2016, buying an estimated $6.34K and bringing the position to 21,347 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3474.

BlackRock Fund Advisors first reported a position in CRMD in Q1 2015 and has held it in 8 quarters since. The position peaked at $3.17M in Q2 2015. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

BlackRock Fund Advisors held 21,347 shares of CorMedix worth $163K as of Q4 2016.
BlackRock Fund Advisors bought 627 CorMedix shares in Q4 2016, an estimated $6.34K.
CorMedix made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3474 holding.
BlackRock Fund Advisors first reported a position in CorMedix in Q1 2015 and has held it in 8 quarters since.
BlackRock Fund Advisors's CorMedix position peaked at $3.17M in Q2 2015.
38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.